Sorrento Therapeutics, Inc. announced that Kevin M. Herde has been appointed to the position of Executive Vice President & Chief Financial Officer. Mr. Herde joins Sorrento with a proven track record of success and over 20 years of progressive experience in finance, accounting, and general management roles. Most recently he was the Vice President of Global Blood Screening and Alliance Management for Hologic, Inc.